In terms of market side, this report researches the Point-of-Care Molecular Diagnostics revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

The global Point-of-Care Molecular Diagnostics market size in 2023 is 8407.8 million US dollars, and it is expected to be 10916.0 million US dollars by 2030, with a compound annual growth rate of 3.8% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Point-of-Care Molecular Diagnostics market include Abbott Laboratories, Inc., Roche Diagnostics, bioMérieux SA, Danaher Corporation (Beckman Coulter), and Cepheid (a subsidiary of Danaher Corporation). The share of the top 3 players in the Point-of-Care Molecular Diagnostics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Point-of-Care Molecular Diagnostics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. PCR-based accounted for XX% of Point-of-Care Molecular Diagnostics market in 2023. Genetic Sequencing-based share of XX%.
Infectious Diseases accounted for XX% of the Point-of-Care Molecular Diagnostics market in 2023. Oncology accounts for XX%.

Report Includes:
This report presents an overview of global market for Point-of-Care Molecular Diagnostics. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of Point-of-Care Molecular Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Point-of-Care Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Point-of-Care Molecular Diagnostics market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Point-of-Care Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Point-of-Care Molecular Diagnostics sales, projected growth trends, technology, application and end-user industry.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapters 2-4: Segmented the global Point-of-Care Molecular Diagnostics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Point-of-Care Molecular Diagnostics market type, application and country market segmentation data.
Chapter 10: Analysis of the competitive environment of Point-of-Care Molecular Diagnostics market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 11: Analyzes the main companies in the Point-of-Care Molecular Diagnostics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Point-of-Care Molecular Diagnostics market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.

Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Abbott Laboratories, Inc.
Roche Diagnostics
bioMérieux SA
Danaher Corporation (Beckman Coulter)
Cepheid (a subsidiary of Danaher Corporation)
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
Hologic, Inc.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company (BD)
GenMark Diagnostics, Inc.
Meridian Bioscience, Inc.
Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific)
Biocartis Group NV
QuantuMDx Group Limited

Types list
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based

Application list
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other

Table of Content

1 Point-of-Care Molecular Diagnostics Market Introduction and Overview
1.1 Point-of-Care Molecular Diagnostics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Point-of-Care Molecular Diagnostics Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type
3 Global Point-of-Care Molecular Diagnostics Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Point-of-Care Molecular Diagnostics Market Size (2019-2024)
4.2 Point-of-Care Molecular Diagnostics Growth Trends Analysis by Regions
4.2.1 Point-of-Care Molecular Diagnostics Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Point-of-Care Molecular Diagnostics Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Point-of-Care Molecular Diagnostics Market Size (2019-2024)
4.2.4 Europe Point-of-Care Molecular Diagnostics Market Size (2019-2024)
4.2.5 Asia-Pacific Point-of-Care Molecular Diagnostics Market Size (2019-2024)
4.2.6 Latin America Point-of-Care Molecular Diagnostics Market Size (2019-2024)
4.2.7 Middle East & Africa Point-of-Care Molecular Diagnostics Market Size (2019-2024)
5 North America
5.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries
5.1.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
5.2 North America Point-of-Care Molecular Diagnostics Revenue by Types
5.3 North America Point-of-Care Molecular Diagnostics Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Countries
6.1.1 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
6.2 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Types
6.3 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries
7.1.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
7.2 Europe Point-of-Care Molecular Diagnostics Revenue by Types
7.3 Europe Point-of-Care Molecular Diagnostics Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Point-of-Care Molecular Diagnostics Revenue by Countries
8.1.1 Latin America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
8.2 Latin America Point-of-Care Molecular Diagnostics Revenue by Types
8.3 Latin America Point-of-Care Molecular Diagnostics Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Countries
9.1.1 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
9.2 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Types
9.3 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Point-of-Care Molecular Diagnostics Market Competition, by Players
10.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Point-of-Care Molecular Diagnostics Players Market Share in 2023
10.2.2 Top 6 Point-of-Care Molecular Diagnostics Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Point-of-Care Molecular Diagnostics Players Head Office, Business Provided
10.4 Point-of-Care Molecular Diagnostics Mergers & Acquisitions
10.5 Point-of-Care Molecular Diagnostics New Entrants and Expansion Plans
11 Players Profiles11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Profile
11.1.2 Point-of-Care Molecular Diagnostics Product Overview
11.1.3 Abbott Laboratories, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.1.4 Abbott Laboratories, Inc. Business Overview
11.1.5 Recent Developments and Plans
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Profile
11.2.2 Point-of-Care Molecular Diagnostics Product Overview
11.2.3 Roche Diagnostics Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.2.4 Roche Diagnostics Business Overview
11.2.5 Recent Developments and Plans
11.3 bioMérieux SA
11.3.1 bioMérieux SA Company Profile
11.3.2 Point-of-Care Molecular Diagnostics Product Overview
11.3.3 bioMérieux SA Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.3.4 bioMérieux SA Business Overview
11.3.5 Recent Developments and Plans
11.4 Danaher Corporation (Beckman Coulter)
11.4.1 Danaher Corporation (Beckman Coulter) Company Profile
11.4.2 Point-of-Care Molecular Diagnostics Product Overview
11.4.3 Danaher Corporation (Beckman Coulter) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.4.4 Danaher Corporation (Beckman Coulter) Business Overview
11.4.5 Recent Developments and Plans
11.5 Cepheid (a subsidiary of Danaher Corporation)
11.5.1 Cepheid (a subsidiary of Danaher Corporation) Company Profile
11.5.2 Point-of-Care Molecular Diagnostics Product Overview
11.5.3 Cepheid (a subsidiary of Danaher Corporation) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.5.4 Cepheid (a subsidiary of Danaher Corporation) Business Overview
11.5.5 Recent Developments and Plans
11.6 QIAGEN N.V.
11.6.1 QIAGEN N.V. Company Profile
11.6.2 Point-of-Care Molecular Diagnostics Product Overview
11.6.3 QIAGEN N.V. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.6.4 QIAGEN N.V. Business Overview
11.6.5 Recent Developments and Plans
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Profile
11.7.2 Point-of-Care Molecular Diagnostics Product Overview
11.7.3 Thermo Fisher Scientific, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.7.4 Thermo Fisher Scientific, Inc. Business Overview
11.7.5 Recent Developments and Plans
11.8 Hologic, Inc.
11.8.1 Hologic, Inc. Company Profile
11.8.2 Point-of-Care Molecular Diagnostics Product Overview
11.8.3 Hologic, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.8.4 Hologic, Inc. Business Overview
11.8.5 Recent Developments and Plans
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Profile
11.9.2 Point-of-Care Molecular Diagnostics Product Overview
11.9.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.9.4 Bio-Rad Laboratories, Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Becton, Dickinson and Company (BD)
11.10.1 Becton, Dickinson and Company (BD) Company Profile
11.10.2 Point-of-Care Molecular Diagnostics Product Overview
11.10.3 Becton, Dickinson and Company (BD) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.10.4 Becton, Dickinson and Company (BD) Business Overview
11.10.5 Recent Developments and Plans
11.11 GenMark Diagnostics, Inc.
11.11.1 GenMark Diagnostics, Inc. Company Profile
11.11.2 Point-of-Care Molecular Diagnostics Product Overview
11.11.3 GenMark Diagnostics, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.11.4 GenMark Diagnostics, Inc. Business Overview
11.11.5 Recent Developments and Plans
11.12 Meridian Bioscience, Inc.
11.12.1 Meridian Bioscience, Inc. Company Profile
11.12.2 Point-of-Care Molecular Diagnostics Product Overview
11.12.3 Meridian Bioscience, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.12.4 Meridian Bioscience, Inc. Business Overview
11.12.5 Recent Developments and Plans
11.13 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific)
11.13.1 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Company Profile
11.13.2 Point-of-Care Molecular Diagnostics Product Overview
11.13.3 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.13.4 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Business Overview
11.13.5 Recent Developments and Plans
11.14 Biocartis Group NV
11.14.1 Biocartis Group NV Company Profile
11.14.2 Point-of-Care Molecular Diagnostics Product Overview
11.14.3 Biocartis Group NV Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.14.4 Biocartis Group NV Business Overview
11.14.5 Recent Developments and Plans
11.15 QuantuMDx Group Limited
11.15.1 QuantuMDx Group Limited Company Profile
11.15.2 Point-of-Care Molecular Diagnostics Product Overview
11.15.3 QuantuMDx Group Limited Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.15.4 QuantuMDx Group Limited Business Overview
11.15.5 Recent Developments and Plans
12 Global Point-of-Care Molecular Diagnostics Forecast Market Analysis by Type
12.1 Global Point-of-Care Molecular Diagnostics Revenue Market Forecast by Type (2024-2030)
13 Global Point-of-Care Molecular Diagnostics Forecast Market Analysis by Application
13.1 Point-of-Care Molecular Diagnostics Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Point-of-Care Molecular Diagnostics Forecast Market Size (2024-2030)
14.2 Point-of-Care Molecular Diagnostics Growth Trends Forecast Analysis by Regions
14.2.1 Point-of-Care Molecular Diagnostics Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Point-of-Care Molecular Diagnostics Forecast Market Size (2024-2030)
14.2.3 Europe Point-of-Care Molecular Diagnostics Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Point-of-Care Molecular Diagnostics Forecast Market Size (2024-2030)
14.2.5 Latin America Point-of-Care Molecular Diagnostics Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Point-of-Care Molecular Diagnostics Forecast Market Size (2024-2030)
15 Point-of-Care Molecular Diagnostics Industry Dynamic Analysis
15.1 Point-of-Care Molecular Diagnostics Market Trends Analysis
15.2 Point-of-Care Molecular Diagnostics Market Drivers Analysis
15.3 Point-of-Care Molecular Diagnostics Market Challenges Analysis
15.4 Point-of-Care Molecular Diagnostics Market Restraints Analysis

List of Tables and Figures

Figure Point-of-Care Molecular Diagnostics Picture
Table Product Definition of Point-of-Care Molecular Diagnostics
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Point-of-Care Molecular Diagnostics Market Size by Type (2019 VS 2024 VS 2030)
Table Global Point-of-Care Molecular Diagnostics Revenue and Market Size by Type (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Market Size by Application (2019 VS 2024 VS 2030)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Size by Application (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2019-2024)
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Size (2019-2024)
Table Point-of-Care Molecular Diagnostics Market Size by Regions: 2019 VS 2024 VS 2030
Table Point-of-Care Molecular Diagnostics Historic Revenue Market Size by Regions (2019-2024)
Table Point-of-Care Molecular Diagnostics Historic Revenue Market Share by Regions (2019-2024)
Figure North America Point-of-Care Molecular Diagnostics Market Size (2019-2024)
Figure Europe Point-of-Care Molecular Diagnostics Market Size (2019-2024)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Market Size (2019-2024)
Figure Latin America Point-of-Care Molecular Diagnostics Market Size (2019-2024)
Figure Middle East & Africa Point-of-Care Molecular Diagnostics Market Size (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure United States Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Canada Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Table Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
Table Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure China Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Japan Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Korea Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Southeast Asia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure India Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Australia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure Germany Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure France Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure UK Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Italy Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Russia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Spain Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Nordic Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure Brazil Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Argentina Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Mexico Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure Egypt Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure South Africa Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure UAE Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Turkey Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Figure Saudi Arabia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue by Players (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share by Players (2019-2024)
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Point-of-Care Molecular Diagnostics Players Market Concentration Ratio (CR5) (2019-2024)
Table Point-of-Care Molecular Diagnostics Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Abbott Laboratories, Inc. Profile
Table Product Overview
Table Abbott Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Abbott Laboratories, Inc. Revenue and Growth Rate
Figure Abbott Laboratories, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Roche Diagnostics Profile
Table Product Overview
Table Roche Diagnostics Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Roche Diagnostics Revenue and Growth Rate
Figure Roche Diagnostics Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table bioMérieux SA Profile
Table Product Overview
Table bioMérieux SA Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure bioMérieux SA Revenue and Growth Rate
Figure bioMérieux SA Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Danaher Corporation (Beckman Coulter) Profile
Table Product Overview
Table Danaher Corporation (Beckman Coulter) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Danaher Corporation (Beckman Coulter) Revenue and Growth Rate
Figure Danaher Corporation (Beckman Coulter) Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Cepheid (a subsidiary of Danaher Corporation) Profile
Table Product Overview
Table Cepheid (a subsidiary of Danaher Corporation) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Cepheid (a subsidiary of Danaher Corporation) Revenue and Growth Rate
Figure Cepheid (a subsidiary of Danaher Corporation) Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table QIAGEN N.V. Profile
Table Product Overview
Table QIAGEN N.V. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure QIAGEN N.V. Revenue and Growth Rate
Figure QIAGEN N.V. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Thermo Fisher Scientific, Inc. Profile
Table Product Overview
Table Thermo Fisher Scientific, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Thermo Fisher Scientific, Inc. Revenue and Growth Rate
Figure Thermo Fisher Scientific, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Hologic, Inc. Profile
Table Product Overview
Table Hologic, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Hologic, Inc. Revenue and Growth Rate
Figure Hologic, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Bio-Rad Laboratories, Inc. Profile
Table Product Overview
Table Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Bio-Rad Laboratories, Inc. Revenue and Growth Rate
Figure Bio-Rad Laboratories, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Becton, Dickinson and Company (BD) Profile
Table Product Overview
Table Becton, Dickinson and Company (BD) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Becton, Dickinson and Company (BD) Revenue and Growth Rate
Figure Becton, Dickinson and Company (BD) Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table GenMark Diagnostics, Inc. Profile
Table Product Overview
Table GenMark Diagnostics, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure GenMark Diagnostics, Inc. Revenue and Growth Rate
Figure GenMark Diagnostics, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Meridian Bioscience, Inc. Profile
Table Product Overview
Table Meridian Bioscience, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Meridian Bioscience, Inc. Revenue and Growth Rate
Figure Meridian Bioscience, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Profile
Table Product Overview
Table Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Revenue and Growth Rate
Figure Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Biocartis Group NV Profile
Table Product Overview
Table Biocartis Group NV Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Biocartis Group NV Revenue and Growth Rate
Figure Biocartis Group NV Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table QuantuMDx Group Limited Profile
Table Product Overview
Table QuantuMDx Group Limited Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure QuantuMDx Group Limited Revenue and Growth Rate
Figure QuantuMDx Group Limited Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Global Point-of-Care Molecular Diagnostics Revenue Market Size Forecast by Type (2024-2030)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share Forecast by Type (2024-2030)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Size by Application (2024-2030)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2024-2030)
Figure Global Point-of-Care Molecular Diagnostics Revenue Forecast Market Size (2024-2030)
Table Point-of-Care Molecular Diagnostics Revenue Forecast Market Size by Regions (2024-2030)
Table Point-of-Care Molecular Diagnostics Revenue Forecast Market Share by Regions (2024-2030)
Figure North America Point-of-Care Molecular Diagnostics Revenue Forecast Market Size (2024-2030)
Figure Europe Point-of-Care Molecular Diagnostics Revenue Forecast Market Size (2024-2030)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Forecast Market Size (2024-2030)
Figure Latin America Point-of-Care Molecular Diagnostics Revenue Forecast Market Size (2024-2030)
Figure Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Forecast Market Size (2024-2030)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis